Pharmaceutical Pricing
-
{
- All
- News
- Videos
-
Centre Directs Strict Vigil To Enforce Lower Prices For 137 Anti-Cancer Drugs
- Friday November 13, 2026
- Health | Indo Asian News Service
The National Pharmaceutical Pricing Authority (NPPA) has directed strict monitoring of the implementation of Trade Margin Rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, for which the reduced prices came into effect from November 9, an official statement said on Friday.
-
www.ndtv.com/health
-
Cancer Drug Prices Slashed By Up To 96.45%; Annual Consumer Savings Pegged At Rs 3,540 Crore: Government
- Monday November 9, 2026
- Health | Indo Asian News Service
The government on Monday said revised prices of 1,364 anti-cancer drug formulations have come into effect, with consumers expected to save an estimated Rs 3,540.38 crore annually following a cap on trade margins for 137 anti-cancer drugs.
-
www.ndtv.com/health
-
Government Cancer Drug Price Curb Likely To Create Rs 3,357 Crore Savings Estimate
- Friday November 6, 2026
- Health | Indo Asian News Service
India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings of Rs 3,357.49 crore, an official factsheet said on Friday.
-
www.ndtv.com/health
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
- Friday October 30, 2026
- Health | Written by Debosmita Ghosh
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
www.ndtv.com/health
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
- Wednesday October 28, 2026
- Health | Reported by Tanushka Dutta
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
www.ndtv.com/health
-
Karnataka Flags Wide Disparity Between Landing Cost And MRP Of High-Cost Drugs And Medical Consumables, Seeks Central Government Intervention
- Thursday October 1, 2026
- Health | Reported by Reethu Rajpurohit
Recent investigations by the Karnataka Food Safety and Drug Administration (FDA) have revealed that pharmaceutical companies are supplying medicines to hospitals at heavily discounted institutional (landing) prices, while patients are being billed at or near the printed MRP.
-
www.ndtv.com/health
-
NPPA Fixes Retail Prices Of 30 Drug Formulations, Including Vitamin D3, Diabetes And Cardiac Medicines
- Sunday May 31, 2026
- Author: NDTV Profit News, Edited by: NDTV Business Desk
The revised prices cover a range of formulations, including Vitamin D3 oral solutions, calcium supplements, diabetes therapies, cardiovascular drugs and antibiotics.
-
www.ndtvprofit.com
-
Centre Cuts Prices Of 35 Essential Medicines
- Sunday August 3, 2025
- India News | Indo-Asian News Service
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
www.ndtv.com
-
Ceiling Prices Of Eight Drugs Used For Asthma, TB, Other Treatments Raised By 50%
- Monday October 14, 2024
- Author: Mohammed Uzair Shaikh
Most of these drugs are low cost and generally used as first-line treatment crucial to the public health programmes of the country, the ministry says.
-
www.ndtvprofit.com
-
Drug-Pricing Regulator Wants Medical Devices Added To Price Control List
- Friday December 8, 2023
- Author: Thomson Reuters
The National Pharmaceutical Pricing Authority (NPPA) had said it did not plan further measures after prices of some heart stents were cut in February by 75 percent
-
www.ndtvprofit.com
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
- Friday December 8, 2023
- Author: Press Trust of India
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
-
www.ndtvprofit.com
-
Merck Gets Demand Notice From Regulator
- Friday December 8, 2023
- Author: Press Trust of India
Merck said the government has issued the demand notice despite the fact that the company was neither a manufacturer nor a marketer of the subject drug.
-
www.ndtvprofit.com
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
- Friday December 8, 2023
- Author: Press Trust of India
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
www.ndtvprofit.com
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
- Friday December 8, 2023
- Author: Press Trust of India
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
www.ndtvprofit.com
-
Centre Directs Strict Vigil To Enforce Lower Prices For 137 Anti-Cancer Drugs
- Friday November 13, 2026
- Health | Indo Asian News Service
The National Pharmaceutical Pricing Authority (NPPA) has directed strict monitoring of the implementation of Trade Margin Rationalisation (TMR) on 137 non-scheduled anti-cancer drugs, for which the reduced prices came into effect from November 9, an official statement said on Friday.
-
www.ndtv.com/health
-
Cancer Drug Prices Slashed By Up To 96.45%; Annual Consumer Savings Pegged At Rs 3,540 Crore: Government
- Monday November 9, 2026
- Health | Indo Asian News Service
The government on Monday said revised prices of 1,364 anti-cancer drug formulations have come into effect, with consumers expected to save an estimated Rs 3,540.38 crore annually following a cap on trade margins for 137 anti-cancer drugs.
-
www.ndtv.com/health
-
Government Cancer Drug Price Curb Likely To Create Rs 3,357 Crore Savings Estimate
- Friday November 6, 2026
- Health | Indo Asian News Service
India's move to cap trade margins on 137 non-scheduled anti-cancer medicines has led 70 companies to cut maximum retail prices by an average 20 per cent to 70 per cent on 120 medicines, with estimated patient savings of Rs 3,357.49 crore, an official factsheet said on Friday.
-
www.ndtv.com/health
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
- Friday October 30, 2026
- Health | Written by Debosmita Ghosh
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
www.ndtv.com/health
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
- Wednesday October 28, 2026
- Health | Reported by Tanushka Dutta
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
www.ndtv.com/health
-
Karnataka Flags Wide Disparity Between Landing Cost And MRP Of High-Cost Drugs And Medical Consumables, Seeks Central Government Intervention
- Thursday October 1, 2026
- Health | Reported by Reethu Rajpurohit
Recent investigations by the Karnataka Food Safety and Drug Administration (FDA) have revealed that pharmaceutical companies are supplying medicines to hospitals at heavily discounted institutional (landing) prices, while patients are being billed at or near the printed MRP.
-
www.ndtv.com/health
-
NPPA Fixes Retail Prices Of 30 Drug Formulations, Including Vitamin D3, Diabetes And Cardiac Medicines
- Sunday May 31, 2026
- Author: NDTV Profit News, Edited by: NDTV Business Desk
The revised prices cover a range of formulations, including Vitamin D3 oral solutions, calcium supplements, diabetes therapies, cardiovascular drugs and antibiotics.
-
www.ndtvprofit.com
-
Centre Cuts Prices Of 35 Essential Medicines
- Sunday August 3, 2025
- India News | Indo-Asian News Service
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
www.ndtv.com
-
Ceiling Prices Of Eight Drugs Used For Asthma, TB, Other Treatments Raised By 50%
- Monday October 14, 2024
- Author: Mohammed Uzair Shaikh
Most of these drugs are low cost and generally used as first-line treatment crucial to the public health programmes of the country, the ministry says.
-
www.ndtvprofit.com
-
Drug-Pricing Regulator Wants Medical Devices Added To Price Control List
- Friday December 8, 2023
- Author: Thomson Reuters
The National Pharmaceutical Pricing Authority (NPPA) had said it did not plan further measures after prices of some heart stents were cut in February by 75 percent
-
www.ndtvprofit.com
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
- Friday December 8, 2023
- Author: Press Trust of India
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
-
www.ndtvprofit.com
-
Merck Gets Demand Notice From Regulator
- Friday December 8, 2023
- Author: Press Trust of India
Merck said the government has issued the demand notice despite the fact that the company was neither a manufacturer nor a marketer of the subject drug.
-
www.ndtvprofit.com
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
- Friday December 8, 2023
- Author: Press Trust of India
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
www.ndtvprofit.com
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
- Friday December 8, 2023
- Author: Press Trust of India
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
www.ndtvprofit.com